These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26919424)

  • 21. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PARP1 expression in pediatric central nervous system tumors.
    Barton VN; Donson AM; Kleinschmidt-DeMasters BK; Gore L; Liu AK; Foreman NK
    Pediatr Blood Cancer; 2009 Dec; 53(7):1227-30. PubMed ID: 19533660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Embryonal tumors with abundant neuropil and true rosettes: a distinctive CNS primitive neuroectodermal tumor.
    Gessi M; Giangaspero F; Lauriola L; Gardiman M; Scheithauer BW; Halliday W; Hawkins C; Rosenblum MK; Burger PC; Eberhart CG
    Am J Surg Pathol; 2009 Feb; 33(2):211-7. PubMed ID: 18987548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
    Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
    Colen RR; Hassan I; Elshafeey N; Zinn PO
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
    Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
    Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in paediatric neuro-oncology.
    Saran F
    Curr Opin Neurol; 2002 Dec; 15(6):671-7. PubMed ID: 12447104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic deletions in cell lines derived from primitive neuroectodermal tumors of the central nervous system.
    Dallas PB; Terry PA; Kees UR
    Cancer Genet Cytogenet; 2005 Jun; 159(2):105-13. PubMed ID: 15899381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Embryonal Tumors of the Central Nervous System: From the Radiologic Pathology Archives.
    Shih RY; Koeller KK
    Radiographics; 2018; 38(2):525-541. PubMed ID: 29528832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the management of pediatric central nervous system tumors.
    Abdullah S; Qaddoumi I; Bouffet E
    Ann N Y Acad Sci; 2008 Sep; 1138():22-31. PubMed ID: 18837879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical molecular pathology and histopathology of embryonal tumors.
    Phillips J; Tihan T; Fuller G
    Surg Pathol Clin; 2015 Mar; 8(1):73-88. PubMed ID: 25783823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central nervous system primitive neuroectodermal tumors: still a useful classification?
    Raffel C; Rutka JT
    Neurosurg Focus; 2011 Jan; 30(1):Introduction. PubMed ID: 21194277
    [No Abstract]   [Full Text] [Related]  

  • 33. Methylation-based algorithms for diagnosis: experience from neuro-oncology.
    Pickles JC; Stone TJ; Jacques TS
    J Pathol; 2020 Apr; 250(5):510-517. PubMed ID: 32057098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomorphologic and clinicoradiologic analysis of primary nonhematologic central nervous system tumors with positive cerebrospinal fluid.
    Ho CY; VandenBussche CJ; Huppman AR; Chaudhry R; Ali SZ
    Cancer Cytopathol; 2015 Feb; 123(2):123-35. PubMed ID: 25487367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric ependymomas: will molecular biology change patient management?
    Grill J; Bergthold G; Ferreira C
    Curr Opin Oncol; 2011 Nov; 23(6):638-42. PubMed ID: 21892086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.
    Washiyama K; Muragaki Y; Rorke LB; Lee VM; Feinstein SC; Radeke MJ; Blumberg D; Kaplan DR; Trojanowski JQ
    Am J Pathol; 1996 Mar; 148(3):929-40. PubMed ID: 8774147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malignant Ectomesenchymoma: Series Analysis of a Histologically and Genetically Heterogeneous Tumor.
    Griffin BB; Chou PM; George D; Jennings LJ; Arva NC
    Int J Surg Pathol; 2018 May; 26(3):200-212. PubMed ID: 28994342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Practical implications of integrated glioma classification according to the World Health Organization classification of tumors of the central nervous system 2016.
    Malzkorn B; Reifenberger G
    Curr Opin Oncol; 2016 Nov; 28(6):494-501. PubMed ID: 27606698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intracranial primitive neuroectodermal tumor in an infant: a case report].
    Yoshizato K; Yoshioka S; Tamai T; Tsuji K; Nishio S
    No Shinkei Geka; 1999 Mar; 27(3):243-8. PubMed ID: 10190159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consensus conference on cancer registration of brain and central nervous system tumors.
    McCarthy BJ; Kruchko C;
    Neuro Oncol; 2005 Apr; 7(2):196-201. PubMed ID: 15831238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.